Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV001729901 | SCV002775345 | uncertain significance | Achromatopsia 2 | 2022-03-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002550195 | SCV002940659 | uncertain significance | not provided | 2022-09-27 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CNGA3 protein function. ClinVar contains an entry for this variant (Variation ID: 1064501). This variant has not been reported in the literature in individuals affected with CNGA3-related conditions. This variant is present in population databases (rs374275399, gnomAD 0.01%). This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 539 of the CNGA3 protein (p.Val539Met). |
Molecular Genetics Laboratory, |
RCV001729901 | SCV001571314 | uncertain significance | Achromatopsia 2 | 2021-04-15 | no assertion criteria provided | research |